Having trouble viewing this email? View in your browser.

14 June 2016

Dear colleagues,

ESCMID’s viral hepatitis study group ESGVH published a review on recent late-stage clinical trials assessing direct-acting antivirals to treat hepatitis C and highlighting the different available regimens and their success rates.

The Royal Society published an interesting report about European Union’s research funding in the United Kingdom. The society’s goal was to gather evidence about the impact on the research landscape of the 23 June 2016 referendum on the UK’s EU membership.

Best regards, your ESCMID communications editors

ESCMID Executive Office
Gerbergasse 14
4001 Basel
Phone +41 61 508 0150
Visit us on mastodon Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.